Home › Cancer (all types) › NCT06306924

UNC Metastatic Cancer Radiation Therapy Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Written informed consent was obtained to participate in the study and HIPAA

Authorization for release of personal health information. Ability to understand and willingness to sign informed consent

Diagnosed with or is suspected to have metastatic cancer.

Age ≥ 18 years at the time of consent.

Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion Criteria:

All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:

Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

About the study

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

What is being tested

• Radiation therapy (radiation)

Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 2,000 · Started: Apr 21, 2024

Contact the study team

• Kadiata Toumbou · Phone: (202) 569-3721

Official record on ClinicalTrials.gov — NCT06306924

Locations in the U.S.

Conditions

• Cancer (all types)
• Metastatic Cancer

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.